Treatment Response to Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy: 96-Week Results From the EXPLORER Cohort of the MAVA-Long-Term Extension Cardiac Magnetic Resonance Imaging Substudy

By afschroeder • September 23, 2025

Saberi S, Kramer CM, Oręziak A, Masri A, Barriales-Villa R, Abraham TP, Lakdawala NK, Wang A, Choudhury L, Rader F, Havakuk O, Stendahl JC, Cardim N, Seidler T, Sherrid M, Hegde SM, Kwong RY, Jerosch-Herold M, Balaratnam G, Kurio G, Fox S, Olivotto I, Owens A. Treatment Response to Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy: 96-Week Results From the EXPLORER Cohort of the MAVA-Long-Term Extension Cardiac Magnetic Resonance Imaging Substudy. Circulation. 2025 Sep 23;152(12):905-908. doi: 10.1161/CIRCULATIONAHA.124.071188. Epub 2025 Sep 22. PMID: 40982583.

Tags: Cardiology/Epi, cardiomyopathies, cardiomyopathy, Cedars Sinai DoM, hypertrophic, Magnetic resonance imaging, Publications

Genetic Reassessment Reveals Catecholaminergic Polymorphic Ventricular Tachycardia in Sisters Initially Diagnosed With Long QT Syndrome

Zhang C, Sarkar A, Wong E, Vaseghi M, Wang JJ. Genetic Reassessment Reveals Catecholaminergic Polymorphic Ventricular Tachycardia in Sisters Initially Diagnosed With Long QT Syndrome.[...]

Adipose Tissue Plasticity, Lipoprotein Metabolism, and Cardiovascular Risk: The Emerging Role of the GLP-1 Axis

Repetti GG, Abel ED, Tontonoz P, Sallam T. Adipose Tissue Plasticity, Lipoprotein Metabolism, and Cardiovascular Risk: The Emerging Role of the GLP-1 Axis. Circ Res.[...]

Translational Theranostics in Glioblastoma: FAPI-46 as a Precision Medicine Tool

Jeanjean P, Swaidan A, Tse C, Kwock S, Fajnorova I, Dove R, Azrour IC, Taylor S, Comin-Anduix B, Nathanson DA, Carlucci G, Calais J, Czernin[...]